Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy

ConditionBlood Loss
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnancy beyond 18 weeks gestational age complicated by genital bleeding;

Age of the patient ≥18 years;

Delivery at the O.U. of Obstetrics and Prenatal Age Medicine

Disqualifiers

None

Trial population

The study will include pregnant patients over 18 weeks of pregnancy referred to the obstetrical emergency department of the division of Obstetrics and Prenatal Age Medicine of IRCCS Azienda Ospedaliero Universitaria di Bologna for genital blood loss.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Rate of hospitalization for genital blood loss

Time frame
After the 18th week of pregnancy
2

Percentage of preterm births

Time frame
After delivery, up to 24 weeks
3

Percentage of spontaneous deliveries, operative vaginal, cesarean sections (elective, urgent, emergent)

Time frame
After delivery, up to 24 weeks
4

Frequency of antihemorrhagic therapy and maternal transfusions

Time frame
Intra-partum and post-partum, up to 24 weeks

Secondary outcomes

1

Frequency of finding abnormal ultrasound findings corresponding to the etiology of bleeding

To assess whether the ultrasound capability in detecting a specific etiology of bleeding has improved over time in conjunction with the evolution of technology and resolution of ultrasound equipment.

Time frame
During the obstetric ultrasound performed at the time of admission

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.